Literature DB >> 17562056

[Crystal-induced arthritis--old but important].

M Winzer1, J Grässler, M Aringer.   

Abstract

Gout is the most common inflammatory arthropathy for men. Asymptomatic hyperuricemia, which should lead to diet, but not to medication, is much more common still. Increased uric acid levels mostly result from diminished renal excretion, which is more commonly familiar than secondary (renal failure, diuretics). With the first episode of often typical (red, hot, exquisitely painful first MTP joint) acute arthritis or with urate nephrolithiasis, increased uric acid turns pathological. Attacks are treated with NSAIDs or corticosteroids. More common attacks, chronic gout, or urate nephropathy are definite indications for long-term (at least 5 years) therapy with allopurinol or febuxostat. Additional anti-inflammatory medication will be necessary during the first months. Calcium pyrophosphate deposition arthropathy, the second common crystal-induced arthritis, is diagnosed by synovial fluid analysis or for chondrocalcinosis. Treatment for attacks resembles therapy of acute gout; causal therapy is possible in case of secondary forms (e.g. hypothyroidism. hyperparathyroidism, hemochromatosis).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562056     DOI: 10.1007/s00393-007-0177-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  20 in total

1.  Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide.

Authors:  C Fernández; R Noguera; J A González; E Pascual
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

Review 2.  Gout: can we create an evidence-based systematic approach to diagnosis and management?

Authors:  Lan X Chen; H Ralph Schumacher
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-08       Impact factor: 4.098

Review 3.  Diagnosis and management of gout.

Authors:  Martin Underwood
Journal:  BMJ       Date:  2006-06-03

4.  Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.

Authors:  Fernando Perez-Ruiz; Joana Atxotegi; Iñaki Hernando; Marcelo Calabozo; Joan M Nolla
Journal:  Arthritis Rheum       Date:  2006-10-15

5.  Spot urine uric acid to creatinine ratio used in the estimation of uric acid excretion in primary gout.

Authors:  Y Moriwaki; T Yamamoto; S Takahashi; J Yamakita; Z Tsutsumi; T Hada
Journal:  J Rheumatol       Date:  2001-06       Impact factor: 4.666

Review 6.  Colchicine for acute gout.

Authors:  N Schlesinger; R Schumacher; M Catton; L Maxwell
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

7.  Febuxostat compared with allopurinol in patients with hyperuricemia and gout.

Authors:  Michael A Becker; H Ralph Schumacher; Robert L Wortmann; Patricia A MacDonald; Denise Eustace; William A Palo; Janet Streit; Nancy Joseph-Ridge
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

Review 8.  Familial calcium crystal diseases: what have we learned?

Authors:  I Maldonado; A M Reginato; A J Reginato
Journal:  Curr Opin Rheumatol       Date:  2001-05       Impact factor: 5.006

Review 9.  Calcium crystal-induced inflammation.

Authors:  P B Halverson; B A Derfus
Journal:  Curr Opin Rheumatol       Date:  2001-05       Impact factor: 5.006

10.  The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994.

Authors:  Holly Mattix Kramer; Gary Curhan
Journal:  Am J Kidney Dis       Date:  2002-07       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.